Related Experiment Video
Updated: Jun 30, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal
Carl E Allen1, Jianguo Du, Bo Jiang
1Center for Cell and Developmental Biology, The Research Institute at Nationwide Children's Hospital and the Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43205, USA.
Abstract:
A substantial body of evidence implicates TGFbeta as a tumor promoter in epithelial cells that have become resistant to its tumor suppressor activity. To better understand early, genome-wide TGFbeta responses in cells resistant to growth inhibition by TGFbeta, we used microarray analysis in a well-defined cell culture system of sensitive and resistant intestinal epithelial cells. TGFbeta-regulated gene expression in TGFbeta-growth-sensitive, nontransformed rat intestinal epithelial cells (RIE-1) was compared to expression in TGFbeta-growth-resistant RIE cells stably transformed by oncogenic Ras(12V). Treatment of RIE-1 cells with 2 ng/ml TGFbeta1 for 1 hour increased the expression of eight gene sequences by 2.6-fold or more, whereas eight were down regulated 2.6-fold. In RIE-Ras(12V) cells, 42 gene sequences were upregulated and only 3 were down-regulated. Comparison of RIE and RIE-Ras(12V) identified 37 gene sequences as unique, Ras-dependent genomic targets of TGFbeta1. TGFbeta-regulation of connective tissue growth factor and vascular endothelial growth factor, two genes up-regulated in RIE-Ras cells and previously implicated in tumor promotion, was independently confirmed and further characterized by Northern analysis. Our data indicate that overexpression of oncogenic Ras in intestinal epithelial cells confers a significantly expanded repertoire of robust, early transcriptional responses to TGFbeta via signaling pathways yet to be fully elucidated but including the canonical Raf-1/MAPK/Erk pathway. Loss of sensitivity to growth inhibition by TGFbeta does not abrogate TGFbeta signaling and actually expands the early transcriptional response to TGFbeta1. Expression of some of these genes may confer to Ras-transformed cells characteristics favorable for tumor promotion.
Insights
Transforming growth factor beta (TGFbeta) promotes tumors in resistant epithelial cells. Oncogenic Ras expands TGFbeta
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Transforming growth factor beta (TGFbeta) acts as a tumor suppressor in normal epithelial cells.
- However, in resistant cells, TGFbeta can paradoxically promote tumor growth.
- Understanding TGFbeta's role in resistant cells is crucial for cancer research.
Purpose of the Study:
- To investigate early, genome-wide TGFbeta responses in intestinal epithelial cells resistant to TGFbeta's growth inhibitory effects.
- To compare TGFbeta-regulated gene expression in normal versus oncogenic Ras-transformed cells.
- To identify specific genes and pathways involved in TGFbeta-mediated tumor promotion in resistant cells.
Main Methods:
- Microarray analysis was performed on sensitive (RIE-1) and resistant (RIE-Ras(12V)) rat intestinal epithelial cells.
- Cells were treated with TGFbeta1, and gene expression changes were analyzed.
- Key gene regulations were confirmed using Northern analysis.
Main Results:
- TGFbeta1 treatment induced significant gene expression changes in both cell types.
- Resistant RIE-Ras(12V) cells showed a substantially expanded transcriptional response to TGFbeta1 compared to RIE-1 cells (42 upregulated vs. 8 upregulated).
- 37 unique, Ras-dependent TGFbeta1 genomic targets were identified, including connective tissue growth factor and vascular endothelial growth factor.
Conclusions:
- Loss of sensitivity to TGFbeta growth inhibition does not abolish TGFbeta signaling; it expands the early transcriptional response.
- Oncogenic Ras in intestinal epithelial cells significantly broadens the cellular response to TGFbeta.
- Upregulated genes in Ras-transformed cells may contribute to tumor promotion characteristics.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation

